Article | February 17, 2021

Ocular Drug Delivery – Developing Polymeric Implants And Other Formulations For Precise Intravitreal Administration

By Troy Carter, R&D Manager for Advanced Drug Delivery at Evonik Health Care

Evonik2-bucket

The development of polymeric formulations such as intra-ocular implants designed for the precise intravitreal delivery of drug products represents one of the most promising, yet challenging, areas of pharmaceutical focus today. To address the specific safety, biocompatibility and extended release requirements of intra-ocular implant formulations, the industry has created highly specialized polymeric biomaterials and process technologies that can enhance product performance and commercial scalability. This article will review key challenges and emerging opportunities for ocular drug delivery, as well as some of the latest excipients and process options that are available today.

VIEW THE ARTICLE!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online